iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Pursue Wealth Partners LLC

Pursue Wealth Partners LLC cut its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 27.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 18,332 shares of the financial services provider’s stock after selling 6,907 shares during the period. iShares Biotechnology ETF comprises approximately 1.6% of Pursue Wealth Partners LLC’s investment portfolio, making the stock its 19th biggest holding. Pursue Wealth Partners LLC’s holdings in iShares Biotechnology ETF were worth $2,490,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in IBB. Transcend Capital Advisors LLC raised its position in shares of iShares Biotechnology ETF by 4.7% in the fourth quarter. Transcend Capital Advisors LLC now owns 10,975 shares of the financial services provider’s stock worth $1,491,000 after acquiring an additional 497 shares during the period. Parametrica Management Ltd acquired a new position in shares of iShares Biotechnology ETF in the fourth quarter worth about $1,019,000. Valmark Advisers Inc. acquired a new position in shares of iShares Biotechnology ETF in the fourth quarter worth about $225,000. GAMMA Investing LLC acquired a new position in shares of iShares Biotechnology ETF in the fourth quarter worth about $51,000. Finally, SlateStone Wealth LLC raised its position in shares of iShares Biotechnology ETF by 3.6% in the fourth quarter. SlateStone Wealth LLC now owns 26,356 shares of the financial services provider’s stock worth $3,580,000 after acquiring an additional 906 shares during the period. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Trading Up 0.7 %

Shares of iShares Biotechnology ETF stock traded up $0.82 during trading hours on Friday, reaching $126.49. The stock had a trading volume of 833,050 shares, compared to its average volume of 1,534,186. The stock’s 50 day moving average is $134.27 and its 200 day moving average is $129.74. iShares Biotechnology ETF has a twelve month low of $111.83 and a twelve month high of $141.16.

iShares Biotechnology ETF Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 27th. Shareholders of record on Friday, March 22nd were given a $0.126 dividend. The ex-dividend date of this dividend was Thursday, March 21st. This represents a $0.50 dividend on an annualized basis and a dividend yield of 0.40%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.